710-1142

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2012-10-02

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2012-10-04 (study day 3.0); relationship: REMOTE

mild assessed

Mild HEADACHE — outcome: RECOVERED/RESOLVED; onset 2012-10-04 (study day 3.0); relationship: REMOTE

moderate assessed

Moderate MYOCARDIAL INFARCTION — outcome: RECOVERED/RESOLVED; onset 2012-10-19 (study day 18.0); relationship: POSSIBLE; serious criteria: hospitalization

mild assessed

Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2012-10-14 (study day 13.0); relationship: NONE

moderate assessed

Moderate SYNCOPE VASOVAGAL — outcome: RECOVERED/RESOLVED; onset 2012-10-19 (study day 18.0); relationship: POSSIBLE

Data queries

No data queries.